explan
principl
mechan
involv
peac
coexist
anim
huge
divers
everchang
microbiota
resid
mucos
surfac
repres
challeng
puzzl
fundament
everyday
surviv
addit
mechan
barrier
varieti
innat
defens
factor
mucos
immunoglobulin
ig
provid
protect
two
complementari
mechan
specif
antibodi
activ
innat
ig
glycanmedi
bind
serv
contain
mucos
microbiota
physiolog
nich
thu
interact
bacteri
ligand
iga
glycan
constitut
discret
mechan
independ
antibodi
specif
oper
primarili
intestin
tract
mucos
site
far
heavili
colon
enorm
divers
bacteri
popul
well
abund
product
site
antibodi
predominantli
iga
isotyp
entir
immun
system
embodi
adapt
innat
immun
mechan
within
singl
molecul
siga
maintain
comprehens
protect
mucos
surfac
economi
structur
function
larg
surfac
area
mucos
membran
constant
contact
highli
divers
microbiota
estim
compris
speci
genera
exceed
total
number
nucleat
cell
order
magnitud
nucleat
cell
vs
bacteri
cell
commens
bacteria
found
gastrointestin
tract
particularli
larg
intestin
evolut
select
pressur
aris
environment
antigen
microbi
food
origin
result
strateg
function
advantag
distribut
cell
involv
antigen
uptak
process
initi
immun
respons
mucos
tissu
mucos
immun
system
contain
antigen
onslaught
without
compromis
integr
mucos
barrier
exhaust
immun
system
part
induct
mucos
oral
toler
addit
mechan
barrier
humor
effector
innat
immun
mucos
antibodi
mucos
cell
provid
antigenspecif
protect
characterist
distribut
antibodi
blood
extern
secret
includ
intestin
fluid
reflect
function
adapt
variou
ig
isotyp
differ
immun
compart
given
mucos
membran
import
site
antigen
encount
surpris
antibodi
product
take
place
mucos
tissu
particularli
intestin
rather
bone
marrow
spleen
lymph
node
daili
synthesi
iga
far
exce
igg
igm
igd
ige
combin
importantli
mucos
protect
twothird
total
iga
product
end
extern
secret
quantit
studi
origin
mucos
antibodi
particularli
intestin
tract
demonstr
local
origin
trace
amount
deriv
circul
mucos
microbiota
epitheli
cell
mucos
immun
system
constitut
stabl
interdepend
tripod
maintain
mucos
homeostasi
complex
mechan
exampl
epitheli
cell
display
surfac
receptor
select
exploit
bacteria
adher
apic
surfac
express
basolater
membran
receptor
polymer
ig
receptor
pigr
transport
local
produc
polymer
p
iga
extern
secret
bacteria
tabl
exampl
glycan
adhes
site
receptor
select
bacteria
virus
colon
infect
mucos
surfac
adapt
endogen
intestin
tract
oral
caviti
probabl
also
respiratori
genit
tract
coat
vivo
siga
limit
epitheli
adher
penetr
therebi
confin
mucos
surfac
numer
model
demonstr
role
antibodi
especi
siga
protect
intestin
mucos
tract
convincingli
demonstr
vivo
germfre
colostrumdepriv
newborn
piglet
unlik
human
mice
rat
rabbit
born
without
transplacent
acquir
ig
absenc
matern
well
endogen
antibodi
milkdepriv
piglet
die
septicemia
usual
e
coli
within
day
birth
wherea
milkf
anim
surviv
furthermor
piglet
fed
milk
serum
surviv
oral
challeng
e
coli
wherea
control
anim
depriv
ig
irrespect
sourc
succumb
infect
mice
pigr
copious
express
hepatocyt
case
human
pig
dog
piga
circul
select
transport
bile
thenc
gut
lumen
pathogenspecif
piga
hybridoma
antibodi
deriv
backpack
tumor
protect
mice
oral
challeng
salmonella
enterica
serovar
typhimurium
vibrio
cholera
rotaviru
contrast
igg
hybridoma
antibodi
specif
protect
due
lack
receptormedi
transport
igg
intestin
numer
experi
clearli
demonstr
protect
vivo
depend
presenc
antigenspecif
iga
antibodi
interfer
pathogen
adher
penetr
mucos
barrier
neutral
biolog
activ
antigen
virus
toxin
likewis
mani
vitro
studi
specif
antibodymedi
inhibit
bacteri
adher
epitheli
cell
corrobor
find
howev
agglutin
inhibit
adher
e
coli
type
fimbria
colon
epitheli
cell
express
correspond
receptor
mediat
iga
independ
specif
antibodi
siga
iga
myeloma
protein
subclass
agglutin
e
coli
mannos
man
inhibit
agglutin
furthermor
adher
e
coli
human
epitheli
colon
cell
inhibit
siga
well
myeloma
protein
analysi
carbohydr
composit
complet
primari
structur
oligosaccharid
sidechain
reveal
activ
myeloma
protein
contain
sever
manrich
nlink
glycan
chain
thu
mandepend
adher
e
coli
epitheli
cell
receptor
mediat
type
fimbria
competit
inhibit
similar
glycan
siga
myeloma
protein
act
decoy
receptor
consequ
propos
iga
protein
exhibit
protect
function
antibodydepend
specif
immun
well
glycandepend
innat
immun
concept
confirm
vitro
microbi
ligandglycan
receptor
addit
e
coli
mani
bacteria
helicobact
pylori
streptococcu
pneumonia
clostridium
difficil
shigella
flexneri
pseudomona
aeruginosa
neisseria
gonorrhoea
virus
tabl
interact
epitheli
receptor
via
glycan
moieti
thu
becom
obviou
nand
oglycan
siga
provid
link
innat
glycanmedi
adapt
specif
antibodydepend
protect
fig
concept
paramount
import
igamedi
mucos
defens
prompt
addit
consider
first
shown
bacteria
indigen
oral
caviti
intestin
tract
coat
vivo
iga
howev
known
whether
coat
depend
specif
antibodyantigen
glycanmedi
interact
consid
enorm
number
bacteria
g
intestin
content
divers
speci
genera
larg
number
potenti
antigen
determin
mani
bacteri
structur
unlik
coat
base
exclus
specif
recognit
siga
antibodi
secondli
larg
intestin
cell
domin
contrast
mucos
tissu
antibodi
antigen
eg
endotoxin
gram
fig
model
human
dimer
siga
molecul
assign
adapt
specificantibodi
activ
innat
glycandepend
activ
asteriskposs
nglycosyl
site
within
segment
vh
region
chain
neg
bacteria
associ
predominantli
subclass
thirdli
addit
glycan
h
chain
iga
secretori
compon
sc
extracellular
segment
pigr
extrem
rich
glycan
compris
nlink
chain
also
act
highli
effect
inhibitor
adher
bacteri
speci
eg
shigella
pneumonia
final
prevent
adher
enorm
divers
variabl
mucos
microbiota
like
least
partial
independ
specif
antibodi
activ
reflect
immedi
need
protect
broad
spectrum
daili
encount
microorgan
thu
concert
postul
fabmedi
polyreact
siga
antibodi
glycanmedi
interact
like
enforc
protect
function
siga
skeptic
concept
may
argu
mucos
defens
igadefici
individu
significantli
compromis
inde
major
patient
display
higher
incid
respiratori
intestin
infect
current
iga
defici
defin
mg
ml
serum
regardless
siga
taken
account
although
usual
also
diminish
complet
absenc
iga
sera
secret
igadefici
patient
extrem
rare
possibl
even
low
level
siga
may
provid
level
protect
furthermor
igadefici
individu
siga
replac
sigm
thu
igadefici
individu
total
igcontain
cell
intestin
produc
igm
sharp
contrast
normal
individu
larg
intestin
cell
produc
iga
igm
igg
importantli
context
igm
iga
display
mani
common
structur
featur
includ
abil
form
polym
presenc
j
chain
abil
bind
pigr
therebi
form
sccontain
secretori
igm
homolog
primari
structur
domain
ctermin
tailpiec
vh
gene
segment
represent
indic
close
evolutionari
function
similar
structur
homolog
also
extend
glycan
moieti
igm
iga
molecul
display
similar
number
domain
locat
nlink
glycan
sidechain
contain
manrich
chain
therefor
despit
differ
number
agbind
site
igm
iga
dimer
tetram
abil
activ
complement
clear
iga
igm
structur
function
evolutionarili
close
relat
isotyp
structur
studi
human
polyclon
siga
monoclon
myeloma
protein
reveal
consider
heterogen
respect
number
site
attach
composit
primari
structur
glycan
sidechain
like
enorm
biolog
import
differ
microorgan
interact
epitheli
cell
divers
glycan
receptor
heterogen
igaassoci
glycan
afford
varieti
structur
effect
inhibit
interact
glycan
moieti
siga
molecul
associ
h
chain
j
chain
sc
manrich
nlink
glycan
inhibit
bind
type
fimbria
epitheli
receptor
occur
h
chain
howev
bacteria
may
interact
olink
glycan
h
chain
sc
tabl
section
b
although
major
nlink
glycan
found
fc
region
chain
great
heterogen
number
composit
individu
glycan
chain
addit
nlink
glycan
chain
may
also
present
fd
fragment
ntermin
half
chain
compris
vh
domain
within
third
complementaritydetermin
region
author
novel
function
import
studi
propos
high
rate
somat
mutat
take
place
within
intestin
igaproduc
cell
gener
glycosylationsign
sequenc
alter
specif
intestin
iga
antibodi
thu
antigenbind
fab
segment
siga
determin
specif
antibodi
activ
glycandepend
interact
heterogen
nand
olink
sidechain
respect
number
composit
type
glycosid
bond
extend
mani
incomplet
truncat
form
importantli
sharp
contrast
combinatori
possibl
amino
acid
glycan
gener
remark
higher
number
structur
due
varieti
glycosid
bond
thu
sequenc
amino
acid
theoret
gener
distinct
hexapeptid
potenti
differ
hexasaccharid
specif
antibodi
divers
gener
antigenindepend
fashion
differenti
b
lymphocyt
number
mechan
includ
recombin
multipl
vj
l
chain
vdj
h
chain
gene
segment
combinatori
divers
l
h
chain
somat
hypermut
gene
convers
other
result
genet
event
gener
b
lymphocyt
surfac
membran
ig
molecul
accommod
enorm
number
potenti
antigen
lead
antigenspecif
recognit
b
cell
prolifer
differenti
ultim
secret
larg
amount
antigenspecif
antibodi
conceiv
analog
mechan
oper
gener
innat
glycanmedi
mechan
protect
random
gener
enorm
divers
glycan
structur
mucos
glycoprotein
includ
siga
sigm
sc
mucin
lactoferrin
glycan
configur
gener
complement
equal
heterogen
microbi
adhesin
protect
effect
mechan
may
enhanc
subsequ
somat
mutat
within
v
region
h
l
chain
includ
gener
glycosyl
signal
lead
alter
antibodi
specif
parallel
structur
function
explor
principl
adapt
specif
antibodi
innat
glycan
sigamedi
immun
like
gener
novel
approach
design
broadli
protect
compound
work
select
interf
adher
penetr
pathogen
contain
commens
microbiota
resid
mucos
surfac
